Abstract
Background In Japan, as a measure to inhibit the COVID-19 outbreak, voluntary restrictions against going out (VRG) have been applied.
Object Mobility information provided by Apple Inc. and NTT Docomo were assessed in terms of its usefulness in predicting conditions exacerbating an outbreak.
Method A polynomial function was applied to daily Apple and Docomo data to calculate the observed R(t).
Results The correlation coefficient among Apple and Docomo data was 0.91. The adjusted coefficient of determination for R(t) for the whole study period was higher using Docomo data than when Apple data were used. When we regressed R(t) on daily Apple and Docomo data simultaneously, the estimated coefficient of Docomo data was not significant.
Discussion and Conclusion We demonstrated that Apple mobility data might be superior to Docomo data for explaining the entire course of the COVID-19 outbreak in Japan.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All information used for this study has been published. There is therefore no ethical issue related to this study.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.